These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 36738621)

  • 1. Customization of aptamer to develop CRISPR/Cas12a-derived ultrasensitive biosensor.
    Xing W; Li Q; Han C; Sun D; Zhang Z; Fang X; Guo Y; Ge F; Ding W; Luo Z; Zhang L
    Talanta; 2023 May; 256():124312. PubMed ID: 36738621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR-Cas12a-mediated label-free electrochemical aptamer-based sensor for SARS-CoV-2 antigen detection.
    Liu N; Liu R; Zhang J
    Bioelectrochemistry; 2022 Aug; 146():108105. PubMed ID: 35367933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR/Cas12a-Derived electrochemical aptasensor for ultrasensitive detection of COVID-19 nucleocapsid protein.
    Han C; Li W; Li Q; Xing W; Luo H; Ji H; Fang X; Luo Z; Zhang L
    Biosens Bioelectron; 2022 Mar; 200():113922. PubMed ID: 34990959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PAM-free cascaded strand displacement coupled with CRISPR-Cas12a for amplified electrochemical detection of SARS-CoV-2 RNA.
    Shi K; Yi Z; Han Y; Chen J; Hu Y; Cheng Y; Liu S; Wang W; Song J
    Anal Biochem; 2023 Mar; 664():115046. PubMed ID: 36641031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A photocontrolled one-pot isothermal amplification and CRISPR-Cas12a assay for rapid detection of SARS-CoV-2 Omicron variants.
    Sun Q; Lin H; Li Y; Yuan L; Li B; Ma Y; Wang H; Deng X; Chen H; Tang S
    Microbiol Spectr; 2024 Mar; 12(3):e0364523. PubMed ID: 38319081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of antibody-aptamer sandwich-like immunosensor based on RCA and Nicked-PAM CRISPR/Cas12a system for the ultra-sensitive detection of a biomarker.
    Wang W; Geng L; Zhang Y; Shen W; Bi M; Gong T; Hu Z; Guo C; Wang T; Sun T
    Anal Chim Acta; 2023 Dec; 1283():341849. PubMed ID: 37977804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR/Cas12a-based electrochemical biosensor for highly sensitive detection of cTnI.
    Chen H; Li ZY; Chen J; Yu H; Zhou W; Shen F; Chen Q; Wu L
    Bioelectrochemistry; 2022 Aug; 146():108167. PubMed ID: 35623274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Split aptamer regulated CRISPR/Cas12a biosensor for 17β-estradiol through a gap-enhanced Raman tags based lateral flow strategy.
    Li Q; Li X; Zhou P; Chen R; Xiao R; Pang Y
    Biosens Bioelectron; 2022 Nov; 215():114548. PubMed ID: 35870335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly sensitive detection of Salmonella based on dual-functional HCR-mediated multivalent aptamer and amplification-free CRISPR/Cas12a system.
    Qiao Z; Xue L; Sun M; Zhang M; Chen M; Xu X; Yang W; Wang R
    Anal Chim Acta; 2023 Dec; 1284():341998. PubMed ID: 37996158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Switching the Activity of CRISPR/Cas12a Using an Allosteric Inhibitory Aptamer for Biosensing.
    Qin P; Chen P; Deng N; Tan L; Yin BC; Ye BC
    Anal Chem; 2022 Nov; 94(45):15908-15914. PubMed ID: 36327313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aptamer assisted CRISPR-Cas12a strategy for small molecule diagnostics.
    Niu C; Wang C; Li F; Zheng X; Xing X; Zhang C
    Biosens Bioelectron; 2021 Jul; 183():113196. PubMed ID: 33839534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitive aptasensing of ATP based on a PAM site-regulated CRISPR/Cas12a activation.
    Liang P; Lv B; Chen K; Li D
    Mikrochim Acta; 2024 Jun; 191(7):386. PubMed ID: 38867016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR/Cas12a Powered DNA Framework-Supported Electrochemical Biosensing Platform for Ultrasensitive Nucleic Acid Analysis.
    Su J; Ke Y; Maboyi N; Zhi X; Yan S; Li F; Zhao B; Jia X; Song S; Ding X
    Small Methods; 2021 Dec; 5(12):e2100935. PubMed ID: 34928030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Programmable Aptasensor for Regulating CRISPR/Cas12a Activity.
    Yu Y; Li Q; Shi W; Yang Y; He H; Dai J; Mao G; Ma Y
    ACS Sens; 2024 Jan; 9(1):244-250. PubMed ID: 38085648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the Trans-Cleavage Activity of CRISPR-Cas12a (cpf1) for the Development of a Universal Electrochemical Biosensor.
    Dai Y; Somoza RA; Wang L; Welter JF; Li Y; Caplan AI; Liu CC
    Angew Chem Int Ed Engl; 2019 Nov; 58(48):17399-17405. PubMed ID: 31568601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The development of a fluorescence/colorimetric biosensor based on the cleavage activity of CRISPR-Cas12a for the detection of non-nucleic acid targets.
    Wang Y; Peng Y; Li S; Han D; Ren S; Qin K; Zhou H; Han T; Gao Z
    J Hazard Mater; 2023 May; 449():131044. PubMed ID: 36821893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An ultrasensitive CRISPR/Cas12a based electrochemical biosensor for Listeria monocytogenes detection.
    Li F; Ye Q; Chen M; Zhou B; Zhang J; Pang R; Xue L; Wang J; Zeng H; Wu S; Zhang Y; Ding Y; Wu Q
    Biosens Bioelectron; 2021 May; 179():113073. PubMed ID: 33581428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasensitive Point-of-Care Detection of Protein Markers Using an Aptamer-CRISPR/Cas12a-Regulated Liquid Crystal Sensor (ALICS).
    Qi L; Liu J; Liu S; Liu Y; Xiao Y; Zhang Z; Zhou W; Jiang Y; Fang X
    Anal Chem; 2024 Jan; 96(2):866-875. PubMed ID: 38164718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel fluorescence biosensor based on CRISPR/Cas12a integrated MXenes for detecting Aflatoxin B1.
    Wu Z; Sun DW; Pu H; Wei Q
    Talanta; 2023 Jan; 252():123773. PubMed ID: 36081307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-Background CRISPR/Cas12a Sensors for Versatile Live-Cell Biosensing.
    Li QN; Wang DX; Han GM; Liu B; Tang AN; Kong DM
    Anal Chem; 2023 Oct; 95(42):15725-15735. PubMed ID: 37819747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.